Recombinant SARS-CoV-2 Spike antibody (RBD)

Catalog No. ABIN7515594

The Human Monoclonal anti-SARS-CoV-2 Spike antibody has been validated for LFCIA. It is suitable to detect SARS-CoV-2 Spike in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Spike antibody (RBD) (ABIN7515594)

Target: SARS-CoV-2 Spike

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike antibody is un-conjugated

Application: Lateral Flow Chromatographic Immunoassay (LFCIA)

Clone: 1H2-4H3

Product Details anti-SARS-CoV-2 Spike Antibody

Binding Specificity: RBD

Purpose: Human recombinant monoclonal antibody raised against partial recombinant SARS-CoV-2 S RBD.

Specificity: This antibody can target SARS-CoV-2 spike RBD IgG and SARS-CoV-2 spike RBD IgM.

Cross-Reactivity: Human, SARS Coronavirus-2 (SARS-CoV-2)

Immunogen: Original antibody is raised against recombinant protein corresponding to SARS-CoV-2 S RBD.

Isotype: IgG, IgM

Application Details

Application Notes: Lateral-Flow Immunochromatographic Assay (This product is the prepared positive control for the assay.) (Once the rapid test card is ready, pipette 10 μLof such product, then add 100 μLof sample diluent buffer into the sample hole for control (10 uL/tes

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In 0.01 M PBS.

Storage: -20 °C

Storage Comment: Store at -20°C for long term storage.
Aliquot to avoid repeated freezing and thawing.

Target Details for SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike

Target Type: Viral Protein